Skip to main content
SleepCited

メラトニン 交代勤務睡眠障害

A

合計1,917名の参加者を対象とした33件の研究(メタアナリシス4件、RCT 2件を含む)に基づく。33件中19件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dshift\u002Dwork\u002Dsleep\u002Ddisorder'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Melatonin may help shift workers get better sleep by supporting the body's adjustment to irregular schedules, though results can vary from person to person.

  • 33 studies including 4 meta-analyses and 2 RCTs examine this use
  • 58% of studies show positive effects for shift work sleep problems
  • Systematic reviews of healthcare workers specifically support melatonin use
  • Strategic timing of melatonin around desired sleep periods may improve effectiveness

Key Study Findings

review
Shift work sleep disorder.
Dose: melatonin, light therapy, prescription medications (modafinil/armodafinil); optimized shift schedule vs: Placebo 効果: None None
In Vitro
Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, …
Dose: 1.57 and 3.67 mM vs: Basal defined media without L-cysteine Outcome: Biofilm formation and motility of L. monocytogenes 効果: None None

対象集団: Listeria monocytogenes 10403S and ctaP mutant

Other
Melatonin-Loaded Hydrogel Modulates Circadian Rhythms and Alleviates Oxidative Stress and Inflammation to Promote Wound Healing.
Dose: None vs: Wounds without hydrogel Outcome: Wound healing and circadian rhythm modulation 効果: None None

対象集団: Animal wound model with circadian disruption

Review
Circadian rhythms and breast cancer: from molecular level to therapeutic advancements.
Dose: None vs: None Outcome: Inflammatory markers 効果: None None

対象集団: Cancer patients

Other
Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice.
Dose: None vs: None Outcome: Fibrosis markers 効果: None None

対象集団: Mouse model

systematic review
The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A …
Dose: 1–10 mg vs: Placebo 効果: None None

Key Statistics

51

研究数

1903

参加者数

Positive

A

グレード

Referenced Papers

Handbook of clinical … 2025 10 件の引用
Current neuropharmacology 2022 40 件の引用
Journal of environmental … 2022 9 件の引用
Chronobiology international 2021 47 件の引用
Critical reviews in … 2021 3 件の引用
Journal of biological … 2020 110 件の引用
Sexual medicine reviews 2018 74 件の引用
Current biology : … 2017 455 件の引用
FP essentials 2017 15 件の引用
Diabetes, obesity & … 2015 132 件の引用
Sleep medicine clinics 2015 75 件の引用
Pathologie-biologie 2014 467 件の引用
The Cochrane database … 2014 131 件の引用
Continuum (Minneapolis, Minn.) 2013 172 件の引用
Methods in molecular … 2013
Nihon rinsho. Japanese … 2013
Cleveland Clinic journal … 2011 73 件の引用
Postgraduate medicine 2011
Journal of pineal … 2011
The International journal … 2010 55 件の引用
Current treatment options … 2010
Tidsskrift for den … 2009 6 件の引用
Arzneimittel-Forschung 2008 89 件の引用
Sleep medicine 2007 201 件の引用
Cellular and molecular … 2007 88 件の引用
The American journal … 2007 3 件の引用
The FEBS journal 2006 56 件の引用
Tidsskrift for den … 2006
Bulletin de l'Academie … 2005
Experimental gerontology 2001 178 件の引用
Novartis Foundation symposium 2000 47 件の引用
Current treatment options … 1999 23 件の引用
Postgraduate medical journal 1998 17 件の引用
Journal of biological … 1997 255 件の引用
Duodecim; laaketieteellinen aikakauskirja 1991

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

上限量: No established UL; 5 mg typically considered maximum

研究で検討された用量

用量 期間 効果 N
melatonin, light therapy, prescription medications (modafinil/armodafinil); optimized shift schedule -- Mixed --
1.57 and 3.67 mM -- Mixed --
None -- Positive --
None -- Positive --
None -- Positive --
1–10 mg -- Positive --
None -- Mixed --
Melatonin (various doses); light therapy; chronotherapy (various schedules) -- Positive --

推奨摂取タイミング: 30-60 minutes before bed

Safety & Side Effects

報告されている副作用

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

既知の相互作用

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

耐容上限摂取量: No established UL; 5 mg typically considered maximum

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does メラトニン help with 交代勤務睡眠障害?
Based on 51 studies with 1,903 participants, there is strong evidence from multiple clinical trials that メラトニン may support 交代勤務睡眠障害 management. Our evidence grade is A (Strong Evidence).
How much メラトニン should I take for 交代勤務睡眠障害?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of メラトニン?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for メラトニン and 交代勤務睡眠障害?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 51 peer-reviewed studies with 1,903 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: 交代勤務睡眠障害

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。